Hormonal acne and PCOS: when adult acne is actually endocrinology

Women in their 20s, 30s, and 40s with persistent acne — particularly along the jawline — are often told it's "just adult acne." Many are spending years on topical retinoids and benzoyl peroxide that produce limited results. In a meaningful fraction of these cases, the acne is the visible signal of underlying hyperandrogenism, most commonly PCOS.

What hormonal acne looks like

Distinguishing features that point toward hormonal rather than primarily topical cause: location concentrated on jawline, chin, and neck (vs forehead and T-zone for sebum-driven adolescent-pattern acne); cystic, deep, painful lesions rather than superficial whiteheads; flare pattern correlated with the menstrual cycle, typically worsening 7–10 days before menses; persistence beyond adolescence; resistance to topical therapy alone.

The androgen connection

Sebaceous glands have androgen receptors. Elevated testosterone or its more potent metabolite dihydrotestosterone (DHT) stimulates sebum production and follicular keratinization, creating the conditions for hormonal acne. In PCOS, elevated free testosterone (driven by hyperinsulinemia reducing SHBG, or by direct ovarian/adrenal androgen excess) creates this picture systemically.

This is why hormonal acne often coexists with other hyperandrogenism markers: hirsutism (terminal hair growth on upper lip, chin, chest, abdomen), androgenic alopecia (thinning at the crown), oily skin, and sometimes skin tags or acanthosis nigricans (when insulin resistance is also present).

When to investigate beyond skin

Workup is warranted when: hormonal-pattern acne persists past age 25 with limited topical response; cystic painful lesions are present; cycle is irregular (over 35 days or under 21 days, or fewer than 9 cycles/year); other hyperandrogenism signs are present; rapid acne onset in adult woman (rare but can signal androgen-secreting tumor).

Standard workup: total and free testosterone, DHEA-S, SHBG, fasting insulin and glucose, TSH, 17-hydroxyprogesterone (rule out non-classical CAH), prolactin. Pelvic ultrasound if cycle pattern suggests PCOS. If acne onset is rapid or severe, expedited workup with same labs plus dermatology evaluation.

Systemic treatment options

Spironolactone is first-line for hormonal acne in women — blocks androgen receptors directly, reducing sebum production. Standard dose 50–150 mg/day; effects appear at 8–12 weeks. Combined hormonal contraception with drospirenone (Yaz, Yasmin) or norgestimate (Ortho Tri-Cyclen) adds androgen suppression through SHBG elevation and ovulation suppression.

For severe cystic acne unresponsive to spironolactone plus OCP after 6 months, isotretinoin (Accutane) is considered. iPLEDGE program enrollment is required given teratogenicity. Course duration typically 6–9 months; results often durable.

For PCOS-driven hormonal acne with metabolic features, metformin or GLP-1 medications can be additive — addressing the insulin-resistance driver upstream of the androgen excess.

What still matters for topicals

Topical retinoids (tretinoin, adapalene, tazarotene) remain important even when systemic therapy is added — they address the follicular component that systemic anti-androgens don't fully resolve. Topical clindamycin or benzoyl peroxide for inflammatory lesions. Avoid pore-clogging cosmetics. The combination of systemic (root cause) plus topical (follicular) outperforms either alone for moderate-to-severe hormonal acne.

When acne goes with other systemic signs

Cystic nodules without surface response to topicals warrant dermatology referral. Hirsutism plus irregular periods strongly suggests PCOS — request full hormonal workup. Sudden severe onset in an adult woman without prior history requires rapid workup to exclude androgen-secreting tumor (rare but treatable when identified early).

Informational only — workup and treatment require evaluation by clinicians familiar with both endocrinology and dermatology.